#$%^&*AU2014240276A120141023.pdf#####ABSTRACT The invention relates to the use as biomarkers of resistance to infections in humans of one or several agonists of the formyl peptide receptors (FPR) receptors family and formyl peptide receptors-like 1 (FPRL1). Said biomarkers are useful in diagnostics, prophylaxis and therapeutics.